Victory Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Sell |
17,330
-50,382
| -74% | -$862K | ﹤0.01% | 2164 |
|
|
2025
Q1 | $4.32M | Sell |
67,712
-21,096
| -24% | -$1.35M | ﹤0.01% | 1322 |
|
|
2024
Q4 | $10.8M | Buy |
88,808
+22,529
| +34% | +$2.74M | 0.01% | 1066 |
|
|
2024
Q3 | $8.28M | Sell |
66,279
-16,794
| -20% | -$2.1M | 0.01% | 1162 |
|
|
2024
Q2 | $13.1M | Buy |
83,073
+11,087
| +15% | +$1.75M | 0.01% | 978 |
|
|
2024
Q1 | $9.32M | Sell |
71,986
-3,046
| -4% | -$394K | 0.01% | 1082 |
|
|
2023
Q4 | $7.24M | Sell |
75,032
-12,354
| -14% | -$1.19M | 0.01% | 1157 |
|
|
2023
Q3 | $10.6M | Buy |
87,386
+12,894
| +17% | +$1.56M | 0.01% | 992 |
|
|
2023
Q2 | $8.53M | Sell |
74,492
-3,135
| -4% | -$359K | 0.01% | 1093 |
|
|
2023
Q1 | $10.7M | Buy |
77,627
+20,350
| +36% | +$2.8M | 0.01% | 1005 |
|
|
2022
Q4 | $7.42M | Sell |
57,277
-139,177
| -71% | -$18M | 0.01% | 1111 |
|
|
2022
Q3 | $21.7M | Buy |
196,454
+160,708
| +450% | +$17.8M | 0.03% | 770 |
|
|
2022
Q2 | $2.68M | Sell |
35,746
-17,322
| -33% | -$1.3M | ﹤0.01% | 1387 |
|
|
2022
Q1 | $4.08M | Sell |
53,068
-579,212
| -92% | -$44.5M | ﹤0.01% | 1326 |
|
|
2021
Q4 | $56.9M | Buy |
632,280
+621,740
| +5,899% | +$56M | 0.05% | 514 |
|
|
2021
Q3 | $975K | Buy |
10,540
+610
| +6% | +$56.4K | ﹤0.01% | 1873 |
|
|
2021
Q2 | $772K | Sell |
9,930
-134
| -1% | -$10.4K | ﹤0.01% | 1987 |
|
|
2021
Q1 | $750K | Sell |
10,064
-19,342
| -66% | -$1.44M | ﹤0.01% | 2034 |
|
|
2020
Q4 | $5.01M | Sell |
29,406
-3,502
| -11% | -$597K | 0.01% | 1240 |
|
|
2020
Q3 | $4.62M | Buy |
32,908
+21,631
| +192% | +$3.04M | 0.01% | 1215 |
|
|
2020
Q2 | $1.81M | Sell |
11,277
-11,571
| -51% | -$1.86M | ﹤0.01% | 1472 |
|
|
2020
Q1 | $2.23M | Buy |
22,848
+11,384
| +99% | +$1.11M | ﹤0.01% | 1556 |
|
|
2019
Q4 | $1.48M | Sell |
11,464
-286
| -2% | -$36.9K | ﹤0.01% | 1611 |
|
|
2019
Q3 | $885K | Buy |
+11,750
| New | +$885K | ﹤0.01% | 1724 |
|